Back to Results
First PageMeta Content
Human papillomavirus / Wart / Cervical cancer / Bupropion / Vulvar intraepithelial neoplasia / Vaginal intraepithelial neoplasia / Cervical intraepithelial neoplasia / Merck & Co. / Placebo / Papillomavirus / Medicine / Gardasil


Rx Update Drugs recently approved or pending approval­ EXELON The US Food and Drug Administration (FDA) has given approval to Novartis Pharmaceuticals Corporation (East Hanover, NJ) to market Exelon (rivastigmine tartra
Add to Reading List

Open Document

File Size: 74,68 KB

Share Result on Facebook

City

Wayne / Hanover / /

Company

Turner White Communications Inc. / Novartis Pharmaceuticals Corporation / EXELON / HPV / GARDASIL Merck & Co. Inc. / /

Event

FDA Phase / /

Facility

Whitehouse Station / /

IndustryTerm

treatment for the prevention of cervical cancer / injection site / study protocol / pharmaceutical company press releases / treatment of major depressive disorder / /

MedicalCondition

insomnia / major depressive disorder / Disease Assessment Scale / dementia / headache / nasopharyngitis / seasonal affective disorder / idiopathic Parkinson’s disease / cervical cancer / fever / tremor / cervical intraepithelial neoplasia / genital warts / pain / vomiting / Parkinson’s disease / CIN / noninvasive cervical cancers / adenocarcinoma / /

MedicalTreatment

vaccinations / /

Organization

US Food and Drug Administration / /

Person

Tricia Faggioli / /

/

Position

Hospital Physician / /

Product

rivastigmine tartrate / WELLBUTRIN XL / EXELON / HCl extended-release tablets / recombinant vaccine / /

ProvinceOrState

Pennsylvania / /

Technology

study protocol / /

URL

www.turner-white.com / /

SocialTag